IRIS
BIANCHI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.810
Totale 17.810
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 17.810
Totale 17.810
Salva come PNG Salva come JPEG
Città #
Genova 13.286
Rapallo 1.946
Genoa 1.667
Vado Ligure 872
Bordighera 39
Totale 17.810
Salva come PNG Salva come JPEG
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 176
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 161
Incidence of other neoplasia in Italian melanoma-prone families with p16 (GLy93Trp) mutation 155
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kB/Rel family members 150
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 148
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 145
H and L ferritin gene expression in U937 cells induced to macrophagedifferentiation 144
c-Rel and p65 subunits bind to an upstream NF-kB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cells 142
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 140
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 140
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 138
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 137
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 137
Increased Risk of Colorectal Adenomas in Italian Subjects Carrying the p53 PIN3 A2-Pro72 Haplotype. 136
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 135
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 132
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 130
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation 130
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 130
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 129
A case of chronic myelogenous leukemia with unusual chromosomal abnormality. 129
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 129
Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens 128
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families. 128
Genome-wide association study identifies three new melanoma susceptibility loci 128
Familial Melanoma and Pancreatic Cancer 127
Genetic testing for melanoma 125
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 125
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone-families 125
Nevoid Basal Cell Carcinoma Syndrome in infants: improving diagnosis. 124
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 124
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions. 123
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. 122
Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline Alterations. 122
Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt 122
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 121
Lactoferrin as a possible transcriptional regulator 120
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 120
What is new in melanoma research: genetics and epidemiology of melanoma in 2003? Review of a workshop held in Milan in May 2003 117
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 117
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 117
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 117
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 115
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 115
Effect of endothelial cell conditioned medium on the growth of human bone marrow fibroblasts 114
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study. 114
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 113
On the Xq13 breakpoint: clinical and cytogenetic observations in a patient with acute myelogenous leukemia. 112
Novel MC1R variants in Ligurian melanoma patients and controls 111
An upstream negative regulatory element in human granulocyte-macrophage colony-stimulating factor promoter is recognised by AP1 family members 111
Molecular characterization of an Italian series of sporadic GISTs. 111
Mutation screening of the CDKN2A promoter melanoma families 110
Urinary granulopoietic activity in chronic myelogenous leukemia: follow-up and correlation with various phases of the disease. 110
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. 109
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 108
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 108
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study 107
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment 107
Unusual Ph translocations in CML: four new cases 106
Sporadic Multiple Primary Melanoma Cases : CDKN2A Germline Mutations With A Founder Effect 105
Effect of primaquine on erythrocytes with NADH-methaemoglobin reductase deficiency and low glutathione reductase activity. 105
Electrophoretic pattern of NADPH - dependent oxidoreductive activities in the K562 and HL60 leukemic cell lines 105
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds 105
Lactoferrin binding sites and nuclear localization in K562(S) cells 104
Characterization, localization, and biosynthesis of acetylcholinesterase in K 562 cells 103
A variant in FTO shows association with melanoma risk not due to BMI. 103
Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients 103
Expression and genomic configuration of GM-CSF, IL-3, M-CSFreceptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes 102
Selection criteria for genetic assessment of patients with familial melanoma 102
Karyotype evolution in a case of chronic myelogenous leukemia with an unusual Philadelphia chromosome translocation, t(4;22), and an additional translocation, t(3;5). 102
High prevalence of the Gly101Trp germline mutation in the CDKN2A gene in 62 small Italian families 101
Characterization of a triplex DNA-binding protein encoded by an alternative reading frame of loricrin 101
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma 101
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 101
Masked Philadelphia chromosome caused by translocation (9;11;22) 101
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma 100
INK4/ARF germline alterations in pancreatic cancer patients 100
Ink4/ARF germline mutations and additional neoplasia in pancretic cancer patients and their families 99
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 99
Linkage Analysis in melanoma prone families 99
P16 germline mutations and protein expression in melanoma lesions from familial melanoma patients 99
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 99
Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes 99
Italian Melanoma-prone Families:Germline mutational analysis and Clinical-Epidemiological Characterization 98
Methemoglobin reductase variability as related to NAD glycohydrolase activity. 98
A nuclear factor that Down-Modulates the Granulocyte-Macrophage Colony-Stimulating Factor Expression. 97
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 97
Electrophoreticpattern of NADPH-dependent oxidoreductive activities in K 562 and HL 60 leukemic cell lines 97
MEL-P, a GM-CSF-producing human melanoma cell line 96
On the Interplay of Telomeres, Nevi and the Risk of Melanoma 96
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. 96
Analysis of p16 protein expression in familial melanoma patients: correlation with germline status. 95
Linkage analysis in Italian melanoma-prone families. 94
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 94
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 94
"Gestione Melanoma" un "database" relazionale per lo studio e l’approfondimento della relazione genotipo/fenotipo e genotipo/ambiente nel melanoma familiare e sporadico 93
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma from Liguria 93
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 91
Analisi molecolare del gene PTCH nella Sindrome di Gorlin (Carcinoma Nevo Basocellulare NBCCS) 91
The role of AIRE polymorphisms in melanoma. 91
Totale 11.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.973
article - articoli 40.035
book - libri 0
conference - conferenze 10.755
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.183
Totale 103.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.958 0 0 0 0 444 495 736 281 409 860 550 183
2020/20211.066 72 97 76 75 60 92 60 104 118 109 94 109
2021/20222.208 46 191 149 296 103 130 158 531 71 206 76 251
2022/20232.390 274 152 16 215 478 421 14 139 373 15 249 44
2023/20241.168 60 147 17 121 87 221 70 60 95 27 60 203
2024/2025974 130 263 131 249 201 0 0 0 0 0 0 0
Totale 17.992